Anuncio • May 22
S.C. Romcarbon S.A. to Report Q1, 2026 Results on May 22, 2026 S.C. Romcarbon S.A. announced that they will report Q1, 2026 results on May 22, 2026 Reported Earnings • Apr 23
Full year 2025 earnings released: EPS: RON0 (vs RON0.02 loss in FY 2024) Full year 2025 results: EPS: RON0 (improved from RON0.02 loss in FY 2024). Revenue: RON259.3m (down 16% from FY 2024). Net loss: RON72.1k (loss narrowed 99% from FY 2024). Profit margin: 0% (up from net loss in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 96 percentage points per year, which is a significant difference in performance. Anuncio • Apr 17
S.C. Romcarbon S.A. to Report Fiscal Year 2025 Final Results on Apr 20, 2026 S.C. Romcarbon S.A. announced that they will report fiscal year 2025 final results on Apr 20, 2026 Anuncio • Apr 16
S.C. Romcarbon S.A., Annual General Meeting, May 20, 2026 S.C. Romcarbon S.A., Annual General Meeting, May 20, 2026, at 12:00 E. Europe Standard Time. Location: at the companyd headquarters in 132 transilvania, street, buzau, buzau county, Romania New Risk • Feb 28
New major risk - Revenue and earnings growth Earnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON88.7m market cap, or US$20.6m). Buy Or Sell Opportunity • Dec 04
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 5.5% to RON0.14. The fair value is estimated to be RON0.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 11% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Nov 17
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: RON68.9m (down 19% from 3Q 2024). Net income: RON2.23m (up RON4.79m from 3Q 2024). Profit margin: 3.2% (up from net loss in 3Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Anuncio • Nov 05
S.C. Romcarbon S.A. announces Annual dividend, payable on May 27, 2026 S.C. Romcarbon S.A. announced Annual dividend of RON 0.0029 per share payable on May 27, 2026, ex-date on May 06, 2026 and record date on May 07, 2026. Buy Or Sell Opportunity • Oct 31
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 1.5% to RON0.14. The fair value is estimated to be RON0.11, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 21% in a year. Earnings are forecast to grow by 92% in the next year. Buy Or Sell Opportunity • Oct 06
Now 30% overvalued after recent price rise Over the last 90 days, the stock has risen 14% to RON0.15. The fair value is estimated to be RON0.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 21% in a year. Earnings are forecast to grow by 92% in the next year. Buy Or Sell Opportunity • Sep 18
Now 23% overvalued Over the last 90 days, the stock has fallen 2.4% to RON0.14. The fair value is estimated to be RON0.11, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 21% in a year. Earnings are forecast to grow by 92% in the next year. Reported Earnings • Aug 14
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: RON69.1m (down 4.0% from 2Q 2024). Net income: RON1.18m (up RON4.14m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Aug 08
Now 20% overvalued Over the last 90 days, the stock has fallen 5.1% to RON0.14. The fair value is estimated to be RON0.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 15% in a year. Earnings are forecast to grow by 78% in the next year. New Risk • Jul 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (RON71.6m market cap, or US$16.5m). Buy Or Sell Opportunity • Jul 01
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 7.0% to RON0.14. The fair value is estimated to be RON0.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 15% in a year. Earnings are forecast to grow by 78% in the next year. Reported Earnings • May 19
First quarter 2025 earnings released First quarter 2025 results: Revenue: RON69.1m (down 7.7% from 1Q 2024). Net loss: RON4.93m (loss widened 125% from 1Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Europe. New Risk • Apr 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (RON90.1m market cap, or US$20.6m). Reported Earnings • Mar 05
Full year 2024 earnings released: RON0.023 loss per share (vs RON0.01 loss in FY 2023) Full year 2024 results: RON0.023 loss per share (further deteriorated from RON0.01 loss in FY 2023). Revenue: RON311.1m (up 2.1% from FY 2023). Net loss: RON12.0m (loss widened 135% from FY 2023). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Anuncio • Jan 15
S.C. Romcarbon S.A., Annual General Meeting, Apr 29, 2025 S.C. Romcarbon S.A., Annual General Meeting, Apr 29, 2025. New Risk • Dec 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (RON83.5m market cap, or US$17.6m). Buy Or Sell Opportunity • Dec 13
Now 21% undervalued Over the last 90 days, the stock has risen 3.6% to RON0.16. The fair value is estimated to be RON0.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 5.7% in a year. Earnings are forecast to grow by 88% in the next year. Reported Earnings • Nov 17
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: RON87.8m (up 24% from 3Q 2023). Net loss: RON2.57m (loss widened 194% from 3Q 2023). Reported Earnings • Aug 20
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: RON72.9m (up 5.7% from 2Q 2023). Net loss: RON2.95m (loss widened 2.9% from 2Q 2023). Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: Revenue: RON75.9m (down 16% from 1Q 2023). Net loss: RON2.19m (down 177% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 03
Full year 2023 earnings released: RON0.009 loss per share (vs RON0.11 profit in FY 2022) Full year 2023 results: RON0.009 loss per share (down from RON0.11 profit in FY 2022). Revenue: RON308.8m (down 19% from FY 2022). Net loss: RON4.95m (down 109% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 17
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: RON74.2m (down 23% from 3Q 2022). Net loss: RON871.2k (down 128% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 122% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Sep 25
Now 51% undervalued after recent price drop Over the last 90 days, the stock is down 50%. The fair value is estimated to be RON0.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Aug 16
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: RON71.0m (down 27% from 2Q 2022). Net loss: RON2.87m (down 149% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 137% per year but the company’s share price has only increased by 51% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • May 17
Upcoming dividend of RON0.05 per share at 12% yield Eligible shareholders must have bought the stock before 24 May 2023. Payment date: 15 June 2023. Payout ratio is a comfortable 24% but the company is not cash flow positive. Trailing yield: 12%. Within top quartile of Romanian dividend payers (8.1%). Higher than average of industry peers (3.9%). Upcoming Dividend • Dec 01
Upcoming dividend of RON0.09 per share Eligible shareholders must have bought the stock before 08 December 2022. Payment date: 21 December 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 19%. Within top quartile of Romanian dividend payers (9.2%). Higher than average of industry peers (3.7%). Anuncio • Dec 01
Greenfiber International S.A. agreed to acquire Greentech S.A. from S.C. Romcarbon S.A. (BVB:ROCE) and others. Greenfiber International S.A. agreed to acquire Greentech S.A. from S.C. Romcarbon S.A. (BVB:ROCE) and others on November 29, 2022. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Vice Chairman of the Board Wey Jiann-Shyang was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 26
Upcoming dividend of RON0.01 per share Eligible shareholders must have bought the stock before 03 October 2022. Payment date: 24 October 2022. Trailing yield: 3.5%. Lower than top quartile of Romanian dividend payers (8.2%). Lower than average of industry peers (4.3%). Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Toderita Stefan-Alexandru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 22
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Toderita Stefan-Alexandru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • May 17
Upcoming dividend of RON0.01 per share Eligible shareholders must have bought the stock before 24 May 2021. Payment date: 10 June 2021. Trailing yield: 4.7%. Lower than top quartile of Romanian dividend payers (5.5%). Higher than average of industry peers (2.3%).